#IGCS2026
LightNews LightNews
onclive.bsky.social
📰 Botensilimab/balstilimab produced an estimated 3-year OS rate of 48% in heavily pretreated recurrent ovarian cancer in the ovarian cohort of the phase 1b C-800-01 trial. @danafarber.bsky.social #IGCS2026 #gyncsm #oncology

Read more ➡️: www.onclive.com/view/botensi...
Botensilimab Plus Balstilimab Yields Durable OS in Recurrent Ovarian Cancer | OncLive
The estimated 3-year OS rate with botensilimab plus balstilimab was 48% in heavily pretreated recurrent ovarian cancer in the phase 1b C-800-01 trial.
www.onclive.com
October 5, 2026 at 3:44 PM
gogfoundation.bsky.social
"Join us today for this in-person Industry Supported Symposium in Hall 517CD!

#ClinicalTrials #GynecologicOncology #GOGPartners #GOGF #IGCS2026
October 3, 2026 at 3:00 PM
gogfoundation.bsky.social
Interested in the GOG trials being presented at @IGCS 2026? Learn more through the link in our bio or view the program here: IGCS Program. #GOGFoundation #ClinicalTrials #GynecologicOncology #IGCS2026
October 3, 2026 at 2:36 PM
gogfoundation.bsky.social
"Join us today for this in-person Industry Supported Symposium in Hall 520!

#ClinicalTrials #GynecologicOncology #GOGPartners #GOGF #IGCS2026
October 2, 2026 at 8:00 PM
gogfoundation.bsky.social
"Join us today for this in-person Industry Supported Symposium in Hall 524!

#ClinicalTrials #GynecologicOncology #GOGPartners #GOGF #IGCS2026
October 2, 2026 at 2:01 PM
gogfoundation.bsky.social
"Join us today for this in-person Industry Supported Symposium in Hall 520!

#ClinicalTrials #GynecologicOncology #GOGPartners #GOGF #IGCS2026
October 2, 2026 at 5:00 AM
jomorrison.medsky.social
at #IGCS2026 hearing about fantastic long term outcomes of people with metastatic endometrial MMRd immunotherapy
October 1, 2026 at 2:02 PM
gogfoundation.bsky.social
Interested in the GOG trials being presented at @IGCS 2026? Learn more through the link in our bio or view the program here: IGCS Program. #GOGFoundation #ClinicalTrials #GynecologicOncology #IGCS2026
October 2, 2026 at 12:00 AM
gogfoundation.bsky.social
"Join us today for this in-person Industry Supported Symposium in Hall 524!

#ClinicalTrials #GynecologicOncology #GOGPartners #GOGF #IGCS2026 "
October 1, 2026 at 2:01 PM
gogfoundation.bsky.social
"Join us at IGCS 2026 for this in-person Industry Supported Symposium!

🎟️ Register for the Annual Global Meeting today: https://ow.ly/Nsru50ZNCTz

#ClinicalTrials #GynecologicOncology #GOGPartners #GOGF #IGCS2026 #GCAM #IWishIKnew
September 22, 2026 at 2:00 AM
gogfoundation.bsky.social
"Join us at IGCS 2026 for this in-person Industry Supported Symposium!

🎟️ Register for the Annual Global Meeting today: https://ow.ly/pPGM50ZNCSN

#ClinicalTrials #GynecologicOncology #GOGPartners #GOGF #IGCS2026 #GCAM #IWishIKnew #OvarianCancer #EndometrialCancer
September 19, 2026 at 6:00 PM
gogfoundation.bsky.social
🍽️ Attending #IGCS2026? Join CE Concepts for The FRα Frontier: New Pathways in Platinum-Resistant Ovarian Cancer on Oct. 2 | 7:15–8:00 AM in Hall 524. Learn about FRα-targeted ADCs while earning CME/CE credit. 🔗 https://ow.ly/Ac2y50ZMNyS #OvarianCancer #Oncology
September 12, 2026 at 4:35 AM
gogfoundation.bsky.social
"Join us at IGCS 2026 for this in-person Industry Supported Symposium!

🎟️ Register for the Annual Global Meeting today: https://igcsmeeting.com/register/

#ClinicalTrials #EndometrialCancer #GynecologicOncology #GOGPartners #GOGF #IGCS2026 #GCAM #IWishIKnew
September 9, 2026 at 2:45 AM
gogfoundation.bsky.social
"Join us at IGCS 2026 for this in-person Industry Supported Symposium!

🎟️ Register for the Annual Global Meeting today: https://ow.ly/oCcF50ZHNH1

#ClinicalTrials #OvarianCancer #GynecologicOncology #GOGPartners #GOGF #IGCS2026 "
September 4, 2026 at 12:00 AM